SynthesisPloS one2014

Multi-targeted antiangiogenic tyrosine kinase inhibitors in advanced non-small cell lung cancer: meta-analyses of 20 randomized controlled trials and subgroup analyses.

Wenhua Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.